CENCORA: FORMERLY AMERISOURCEBERGEN
Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 46,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #11 on the Fortune 500 and #24 on the Global Fortune 500 with more than $200 billion in annual revenue. Learn more at www.cencora.com
CENCORA THINKLIVE CELL AND GENE THERAPY VIRTUAL SUMMIT 2025
This two-day virtual summit will bring together the expertise of Cencora and global leaders, providers, and healthcare experts. Our esteemed speakers will provide insights into the advancements shaping the future of healthcare as well as how, together, we can build solutions for tomorrow’s therapies.
Date: May 20 - 21, 2025
Time: 8am – 10:30am PDT / 11am – 1:30pm EDT / 4pm – 6:30pm BST / 5pm – 7:30pm CET
Location: Virtual
CELL & GENE THERAPIES
Your therapy can make all the difference. Together, we'll unlock its potential.
CONTACT INFORMATION
Cencora
1 W 1st Ave.
Conshohocken, PA 19428
UNITED STATES
FEATURED INSIGHTS
-
![GettyImages-1838438985 opthamology]( "The Future Promise Of Advanced Therapies In Ophthalmology")
Six years after the first approved gene therapy in ophthalmology, the field is experiencing a surge of activity. Delve into the exciting potential of advanced therapies for eye diseases.
-
![GettyImages-1414481878 clinical trial, patient, diversity]( "Navigating Patient Access Challenges When Bringing Your CGT Product To Market")
Bringing cell and gene therapies to market requires more than scientific breakthroughs; manufacturers must navigate complex patient access challenges to ensure these innovations reach those in need.
-
![GettyImages-1463492154 nurse]( "Optimizing The Channel Strategy To Expand Patient Access")
Patient access depends on a well-planned channel strategy. Explore key considerations for optimizing distribution, logistics, and patient support in the evolving cell and gene therapy landscape.
EXPLORE OUR THOUGHT LEADERSHIP
Explore the latest insights from the Cencora team.
WEBINARS
-
![Cencora - ATMP webinar Q&A]( "Q&A Interview: Navigating The Launch Of ATMPs In Europe")
Q&A Interview: Navigating The Launch Of ATMPs In EuropeDive into this overview of the evolving regulatory landscape and better understand the importance of proactive planning, collaboration, and expert guidance in navigating the ATMPs ecosystem in Europe.
-
![GettyImages-1196710772 doctors]( "Streamlining Patient Access To Cell And Gene Therapies")
Streamlining Patient Access To Cell And Gene TherapiesLearn about the obstacles patients encounter when seeking CGTs and explore how technology and patient services can empower manufacturers and clinical teams to help patients overcome barriers.
-
![Clinical Collaboration GettyImages-1288871608]( "Webinar: Reimbursement Methods For Sustainable CGT Business Models")
Webinar: Reimbursement Methods For Sustainable CGT Business ModelsLearn more about the key features of successful innovative pricing and reimbursement models as well as outcomes-based agreements and the ways to advance those strategies for cell and gene therapies.
BLOGS
-
![GettyImages-1495393006 opthalmology, eye care]( "A Bright Future For Eye Care: The Advanced Therapy Revolution Is Here")
A Bright Future For Eye Care: The Advanced Therapy Revolution Is HereGroundbreaking cell and gene therapies are revolutionizing eye care. Discover how advanced treatments target root causes, offering unprecedented hope for conditions previously deemed untreatable.
-
![Doctor talking to patient-GettyImages-1330555438]( "Navigating Patient Access Challenges In Commercializing Your CGT Product")
Navigating Patient Access Challenges In Commercializing Your CGT ProductLearn how to effectively break down barriers to patient access in cell and gene therapy by enhancing provider education, streamlining coordination, and expanding patient support.
-
![GettyImages-1938542776 doctor patient]( "Expanding Patient Access To Cell And Gene Therapies: Optimizing Channel Strategy")
Expanding Patient Access To Cell And Gene Therapies: Optimizing Channel StrategyRare disease innovation demands robust channel strategies for patient access. Learn how a patient-centric approach, logistical solutions, and strong partnerships are key to successful patient access.
